Express Pharma

Marksans Pharma gets UK MHRA nod for diarrhoea medication

The capsules will be manufactured at the company's Goa-based oral dosage facility

0 422

Marksans Pharma yesterday said its subsidiary has received market authorisation from the UK health regulator for its anti-diarrhoea medication Loperamide capsules. The UK MHRA has granted market authorisation to the company’s wholly-owned subsidiary Relonchem for Loperamide hard capsules (2mg), Marksans Pharma said in a regulatory filing.

It also said that it will manufacture the product at its Goa-based oral dosage facility.

- Advertisement -